By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Numoda Corporation 

The Curtis Center
601 Walnut Street, 9th Floor
Philadelphia  Pennsylvania  19106-3323  U.S.A.
Phone: 215-238-8881 Fax: 215-238-9995


Company News
Proteonomix, Inc. (PROT) Retains Numoda Corporation to Provide Clinical Trial Services for Phase 1 Trial With UMK-121 in End-Stage Liver Disease 9/12/2012 10:10:01 AM
Proteonomix, Inc. (PROT) Engages Numoda Corporation for Clinical Trial Services 9/4/2012 10:07:05 AM
Cleveland Clinic and Numoda Corporation are Collaborating to Accelerate the Process by Which Research Discoveries are Moved From the Laboratory to Patient Care 7/18/2012 9:29:37 AM
IntelliCell BioSciences (SVFC) Announces Powerful Collaboration with Numoda Corporation 12/13/2011 9:25:33 AM
Pro-Pharmaceuticals, Inc. (PRW) Collaborates with Numoda Corporation to Manage Phase III Clinical Trial to Increase Speed-to-Market for DAVANAT(R) 9/13/2010 9:50:56 AM
Provectus Pharmaceuticals Inc. to Use Numoda Corporation's TruPoints System to Facilitate Transactions with Potential Licensing Partners for PH-10 7/27/2010 10:02:44 AM
Advaxis, Inc. Engages the Numoda Corporation to Oversee Phase II Clinical Trials of ADXS11-001 6/23/2009 11:38:56 AM
DOR BioPharma, Inc. (DORB) Executes $400,000 Equity Investment Agreement With Numoda Corporation 3/25/2009 10:35:40 AM
Columbia Laboratories, Inc. (CBRX) Raises $750,000 through Sale of Common Stock 1/7/2009 8:22:57 AM
DOR BioPharma, Inc. (DORB) Announces Collaboration With Numoda for the Execution of Confirmatory, Phase 3 Clinical Trial of orBec(R) 6/30/2008 8:40:55 AM